Ethosuximide-induced lupus-like syndrome with renal involvement

Internal Medicine

Volumn 35, Issue 7, 1996, Pages 587-591

  Takeda, Shin Ichi ^b   Koizumi, Fumitomo ^a   Takazakura, Eisuke ^b  

^a Pathol Toyama Med P   (Japan)

^b Kurobe City Hospital   (Japan)

Author keywords

anticonvulsant; arteriolar lesion; glomerular lesion; systemic lupus erythematosus

Indexed keywords

ANTINUCLEAR ANTIBODY; ETHOSUXIMIDE;

ADULT; ARTICLE; CASE REPORT; CELL PROLIFERATION; ELECTRON MICROSCOPY; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY BIOPSY; KIDNEY FAILURE; MALE; MESANGIUM CELL; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0029779728     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.35.587     Document Type: Article

References (26)

1. Hess E. Drug-related lupus. N Engl J Med 318: 1460, 1988 (editorial).
2. Skaer TL. Medication-induced systemic lupus erythematosus. Clin Ther 14: 496, 1992.
3. Whittle TS Jr, Ainsworth SK. Procainamide-induced systemic lupus erythematosus. Renal involvement with deposition of immune complexes. Arch Pathol Lab Med 100: 469, 1976.
4. Foucar E, Erickson DG, Tung KSK. Glomerulonephritis in procainamide induced lupus erythematosus: report of a case and review of the literature. J Clin Lab Immunol 2: 79, 1979.
5. Sheikh TK, Charron RC, Katz A. Renal manifestations of drug-induced systemic lupus erythematosus. Am J Clin Pathol 75: 755, 1981.
6. World Health Organization (WHO) Monograph. Lupus nephritis, in: Renal Disease. Classification and Atlas of Glomerular Diseases, Churg J, Sobin LH and pathologists and nephrologists in 14 countries, Eds. Igakushoin, Tokyo, 1982, p. 128.
7. Livingston S, Rodriguez H, Greene CA, Pauli LL. Systemic lupus erythematosus. Occurrence in association with ethosuximide therapy. JAMA 204: 731, 1968.
8. Alter BP. Systemic lupus erythematosus and ethosuccimide. J Pediatr77: 1093, 1970.
9. Dabbous IA, Idriss HM. Occurrence of systemic lupus erythematosus in association with ethosuccimide therapy. Case report. J Pediatr 76: 617, 1970.
10. Teoh PC, Chan HL. Lupus-scleroderma syndrome induced by ethosuximide. Arch Dis Child 50: 658, 1975.
11. Singsen BH, Fishman L, Hanson V. Antinuclear antibodies and lupuslike syndromes in children receiving anticonvulsants. Pediatrics 57: 529, 1976.
12. Rallison ML, Carlisle JW, Lee RE Jr, Vernier RL, Good RA. Lupus erythematosus and Stevens-Johnson syndrome. Occurrence as reactions to anticonvulsant medication. JAMA 101: 725, 1961.
13. Benton JW, Tynes B, Register HB Jr, Alford C, Holley HL. Systemic lupuserythematosus occurring during anticonvulsive drug therapy. JAMA 180: 115, 1962.
14. Stem R, Fishman J, Brusman H, Kunkel HG. Systemic lupus erythematosus associated with Klinefelter's syndrome. Arthritis Rheum 20: 18, 1977.
15. Rutherford BD. Procainamide-induced systemic lupus erythematosus. N Z Med J 68: 235, 1968.
16. Günther R, Asamer H, Dittrich P. Das reversible procainamid-induzierte Lupus-erythematodes-Syndrom. Dtsch Med Wochenschr 94: 2338,1969 (in German).
17. Levo Y, Pick AI, Avidor I, Ben-Bassat M. Clinicopathological study of a patient with procainamide-induced systemic lupus erythematosus. Ann Rheum Dis 35: 181, 1976.
18. Dammin GJ, Nora JR, Reardan JB. Hydralazine reaction. Case with LE cells antemortem and postmortem, and pulmonary, renal, splenic, and muscular lesions of disseminated lupus erythematosus. J Lab Clin Med 46: 806, 1955.
19. Castleman B, McNeely BU. Case records of the Massachusetts General Hospital. Weekly Clinicopathological exercises. Case 21-1968. N Engl J Med 278: 1167, 1968.
20. Alarcón-Segovia D, Wakim KG, Worthington JW, Ward LE. Clinical and experimental studies on the hydralazine syndrome and its relationship to systemic lupus erythematosus. Medicine (Baltimore) 46: 1, 1967.
21. Whittingham S, Mackay IR. Systemic lupus erythematosus induced by procaine amide. Australas Ann Med 19: 358, 1970.
22. Artinian B, Reesal M. Procainamide-induced SLE and lymphoreticular disorders. Can Med Assoc J 110: 314, 1974.
23. Hill GS. Systemic lupus erythematosus and mixed connective-tissue disease. in: Pathology of the Kidney, Heptinstall RH, Ed. Little, Brown and Company, Boston, 1992, p.897.
24. Becker M, Klajman A, Moalem T, Yaretzky A, Ben-Efraim S. Circulating immune complexes in sera from patients receiving procainamide. Clin Immunol Immunopathol 12: 220, 1979.
25. Fritzler MJ, Tan EM. Antibodies to histones in drug-induced and idiopathic lupus erythematosus. J Clin Invest 62: 560, 1978.
26. Schmiedeke TMJ, Stöckl FW, Weber R, Sugisaki Y, Batsford SR, Vogt A. Histones have high affinity for the glomerular basement membrane. Relevance for immune complex formation in lupus nephritis. J Exp Med 169: 1879, 1989.